CCIA
Campbell & Co Investment Adviser’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $706K | Buy |
+1,345
| New | +$706K | 0.04% | 654 |
|
|
2025
Q1 | – | Sell |
-6,882
| Closed | -$4.9M | – | 1287 |
|
|
2024
Q4 | $4.9M | Buy |
6,882
+2,711
| +65% | +$1.93M | 0.38% | 46 |
|
|
2024
Q3 | $4.38M | Buy |
+4,171
| New | +$4.38M | 0.33% | 46 |
|
|
2023
Q1 | – | Sell |
-863
| Closed | -$623K | – | 998 |
|
|
2022
Q4 | $623K | Sell |
863
-2,118
| -71% | -$1.53M | 0.15% | 226 |
|
|
2022
Q3 | $2.05M | Buy |
+2,981
| New | +$2.05M | 0.47% | 23 |
|
|
2020
Q4 | – | Sell |
-800
| Closed | -$448K | – | 539 |
|
|
2020
Q3 | $448K | Buy |
800
+400
| +100% | +$224K | 0.33% | 92 |
|
|
2020
Q2 | $249K | Buy |
+400
| New | +$249K | 0.32% | 149 |
|
|
2019
Q3 | – | Sell |
-921
| Closed | -$288K | – | 737 |
|
|
2019
Q2 | $288K | Sell |
921
-1,468
| -61% | -$459K | 0.13% | 320 |
|
|
2019
Q1 | $981K | Buy |
2,389
+1,713
| +253% | +$703K | 0.48% | 26 |
|
|
2018
Q4 | $280K | Buy |
+676
| New | +$280K | 0.28% | 175 |
|
|
2018
Q1 | – | Sell |
-1,135
| Closed | -$427K | – | 508 |
|
|
2017
Q4 | $427K | Sell |
1,135
-1,081
| -49% | -$407K | 0.32% | 94 |
|
|
2017
Q3 | $991K | Buy |
+2,216
| New | +$991K | 0.8% | 14 |
|
|
2013
Q4 | – | Sell |
-2,802
| Closed | -$877K | – | 293 |
|
|
2013
Q3 | $877K | Buy |
+2,802
| New | +$877K | 0.17% | 145 |
|